School of Medicine
Showing 21-40 of 56 Results
-
Robert Lowsky
Professor of Medicine (Blood and Marrow Transplantation) at the Stanford University Medical Center
Current Research and Scholarly InterestsDr. Lowsky's research is focused on understanding the role of regulatory T cells in the prevention of GVHD and in promoting immune tolerance following organ transplantation.
-
Crystal Mackall
Ernest and Amelia Gallo Family Professor and Professor of Pediatrics and of Medicine
Current Research and Scholarly InterestsRecent clinical studies, by us and others, have demonstrated that T cell based immunotherapy can eradicate cancers resistant to all other available therapies. Our program creates, develops and optimizes genetically engineered T cells to treat cancer. We link the bench with the bedside, developing novel therapies for early phase testing in clinical trials, while simultaneously conducting intensive studies on clinical samples obtained from patients treated on immunotherapy trials.
-
Everett Meyer
Assistant Professor of Medicine (Blood and Marrow Transplantation), of Pediatrics (Stem Cell Transplantation) and, by courtesy, of Surgery (Abdominal Transplantation) at the Stanford University Medical Center
Current Research and Scholarly InterestsResearch focus in T cell immunotherapy and T cell immune monitoring using high-throughput sequencing and genomic approaches, with an emphasis on hematopoietic stem cell transplantation, the treatment of graft-versus-host disease and immune tolerance induction.
-
David Miklos
Associate Professor of Medicine (Blood and Marrow Transplantation) at the Stanford University Medical Center
Current Research and Scholarly InterestsDr. Miklos is the Associate Chief of BMT & Clinical Director of Cancer Cell Therapy. Dr. Miklos leads Stanford’s CAR therapy clinical trials for patients with aggressive lymphomas and directs their multidimensional correlative research studies: 1) tumor antigen quantification, 2) single cell functional product characterization, 3) CAR-FACS immune phenotyping of blood and tumor, and identifying mechanisms for CAR-T treatment Failure including antigen loss, CAR-T exhaustion, and CAR suppression.
-
Dora G. Moscoso
AA and Postdoc Coordinator, Medicine - Med/Blood and Marrow Transplantation
Current Role at StanfordPostdoctoral Fellowship Coordinator and Administrative Assistant to:
David B. Miklos, MD, PhD | Associate Professor of Medicine and Chief
Robert S. Negrin, MD | Professor of Medicine -
Lori Muffly
Assistant Professor of Medicine (Blood and Marrow Transplantation) at the Stanford University Medical Center
Current Research and Scholarly InterestsDr. Muffly's interests include health services research and clinical trials with a focus on acute leukemia and blood and marrow transplantation.
-
Robert Negrin
Professor of Medicine (Blood and Marrow Transplantation)
On Leave from 01/01/2021 To 12/31/2021Current Research and Scholarly InterestsOur labaratory focuses on the study of immune recognition by T and NK cells with special emphasis on graft vs host disease and graft vs tumor reactions. We utilize both murine and human systems in an effort to enhance graft vs tumor reactions while controlling graft vs host disease. We have developed bioluminescence models in collaboration with the Contag laboratory to study the trafficking of immune effector cells with a special emphasis on NK, T and regulatory T cells.
-
Shiva Pathak
Postdoctoral Research Fellow, Bone Marrow Transplantation
BioResearch interests: Pancreatic islet transplantation, Mesenchymal stem cell transplantation, Transplant tolerance, Biomaterials for drug and cell delivery
-
Heather Radford, PA-C
Affiliate, Medicine - Med/Blood and Marrow Transplantation
BioHeather Radford, PA-C is the Lead Advanced Practice Provider for the Blood and Marrow Transplant Program. She completed her MHS and PA studies at Duke University in 2007. She then started her career in inpatient pulmonary and critical care at Johns Hopkins from 2007-2011. She transitioned her practice to the Johns Hopkins inpatient hematologic malignancies and Bone Marrow Transplant program from 2011-2013. She moved back west and landed in beautiful Palo Alto, California. She joined the Stanford BMT program in September 2013 and shortly thereafter was promoted to Lead APP. Her area of clinical practice is bone marrow transplant and cancer cellular therapies. She practices on the inpatient service as well l as the infusion treatment area in addition to her leadership role.
